Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fix-Price's online sales grew 18% in 2023

2/15/24 FIXP

Yandex reported revenue growth in all main directions

2/15/24 YNDX

TGC-14 reported for 2023 by RAS

2/15/24 TGKN

Yandex reported for the year 2023

2/15/24 YNDX

Inter RAO reported for 2023 by RAS

2/15/24 IRAO

Ingrid's sales in 2023 grew by 12%

2/15/24 INGR

Sales of Softline's proprietary solutions in 2023 increased 3-fold

2/15/24 SOFL

Daimler has withdrawn from the capital of Kamaz

2/15/24 KMAZ

UAC reported for 2023 by RAS

2/14/24 UNAC

Russneft reported for 2023 by RAS

2/14/24 RNFT